Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea

Italian Journal of Pediatrics

Volumn 40, Issue 1, 2014, Pages

  Zama, Daniele ^a   Cocchi, Ilaria ^a   Masetti, Riccardo ^a   Specchia, Fernando ^a   Alvisi, Patrizia ^b   Gambineri, Eleonora ^c,d   Lima, Mario ^e   Pession, Andrea ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Forkhead box P3 (FOXP3); Immunodysregulation polyendocrinopathy enteropathy X linked syndrome (IPEX); Sirolimus

Indexed keywords

ALBUMIN; ARGININE; CYCLOSPORIN; HISTIDINE; IMMUNOGLOBULIN E; METHYLPREDNISOLONE; METRONIDAZOLE; RAPAMYCIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ABDOMINAL PAIN; ALBUMIN BLOOD LEVEL; AMINO ACID SUBSTITUTION; ARTICLE; ATOPIC DERMATITIS; BLOOD ANALYSIS; CASE REPORT; CHILD; COLON BIOPSY; COLON ULCER; COLONOSCOPY; CONSTIPATION; DEHYDRATION; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DUODENUM ULCER; ECHOGRAPHY; ENTERITIS; ENTEROPATHY; ESOPHAGOGASTRODUODENOSCOPY; EXON; FOXP3 GENE; GENE; GENE MUTATION; GENETIC ANALYSIS; GRAFT VERSUS HOST REACTION; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPOPROTEINEMIA; ILEOSTOMY; IMMUNE DYSREGULATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; INFLAMMATORY BOWEL DISEASE; IPEX SYNDROME; MALE; MEDICAL HISTORY; PARENTERAL NUTRITION; POLYENDOCRINOPATHY; REMISSION; SCHOOL CHILD; STOMACH BIOPSY; STOMACH ULCER; TERMINAL ILEUM; WEIGHT REDUCTION; COMPLICATION; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; PROTEIN LOSING GASTROENTEROPATHY; REGULATORY T LYMPHOCYTE; SYNDROME; X CHROMOSOME LINKED DISORDER;

CHILD; DIARRHEA; FORKHEAD TRANSCRIPTION FACTORS; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MUTATION; POLYENDOCRINOPATHIES, AUTOIMMUNE; PROTEIN-LOSING ENTEROPATHIES; SYNDROME; T-LYMPHOCYTES, REGULATORY;

EID: 84955123011     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/s13052-014-0068-4     Document Type: Article

References (31)

1. Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, Sartirana C, Matthes-Martin S, Lawitschka A, Azzari C, Ziegler SF, Levings MK, Roncarolo MG: Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006, 116:1713-1722.
2. Wildin RS, Smyk-Pearson S, Filipovich AH: Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002, 39:537-545.
3. Vliet HJJ Van D, Nieuwenhuis EE: IPEX as a Result of Mutations in FOXP3. Clin Dev Immunol 2007, 2007:3-8.
4. Gambineri E, Perroni L, Passerini L, Bianchi L, Doglioni C: Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: Inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol 2008, 122:1105-1113.
5. Peake JE, McCrossin RB, Byrne G, Shepherd R: X-linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea. Arch Dis Child Fetal Neonatal Ed 1996, 74:F195-F199.
6. Baud O, Goulet O, Canioni D, Le Deist F, Radford I, Rieu D, Dupuis-Girod S, Cerf-Bensussan N, Cavazzana-Calvo M, Brousse N, Fischer A, Casanova JL: Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001, 344:1758-1762.
7. Ruemmele FM, Moes N, de Serre NP-M, Rieux-Laucat F, Goulet O: Clinical and molecular aspects of autoimmune enteropathy and immune dysregulation, polyendocrinopathy autoimmune enteropathy X-linked syndrome. Curr Opin Gastroenterol 2008, 24:742-748.
8. Nieves DS, Phipps RP, Pollock SJ, Ochs HD, Zhu Q, Scott GA, Ryan CK, Kobayashi I, Rossi TM, Goldsmith LA: Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch Dermatol 2004, 140:466-472.
9. De Benedetti F, Insalaco A, Diamanti A, Cortis E, Muratori F, Lamioni A, Carsetti R, Cusano R, De Vito R, Perroni L, Gambarara M, Castro M, Bottazzo GF, Ugazio AG: Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome. Clin Gastroenterol Hepatol 2006, 4:653-659.
10. Halabi-Tawil M, Ruemmele FM, Fraitag S, Rieux-Laucat F, Neven B, Brousse N, De Prost Y, Fischer A, Goulet O, Bodemer C: Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br J Dermatol 2009, 160:645-651.
11. Torgerson TR: Regulatory T cells in human autoimmune diseases. Springer Semin Immunopathol 2006, 28:63-76.
12. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
13. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME: X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27:18-20.
14. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM: JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000, 106:R75-R81.
15. Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD, Levine SS, Fraenkel E, von Boehmer H, Young RA: Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007, 445:931-935.
16. Zheng Y, Josefowicz SZ, Kas A, Chu T-T, Gavin MA, Rudensky AY: Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445:936-940.
17. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, Bates DL, Guo L, Han A, Ziegler SF, Mathis D, Benoist C, Chen L, Rao A: FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006, 126:375-387.
18. Bettelli E, Dastrange M, Oukka M: Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 2005, 102:5138-5143.
19. Bindl L, Torgerson T, Perroni L, Youssef N, Ochs HD, Goulet O, Ruemmele FM: Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J Pediatr 2005, 147:256-259.
20. Yong PL, Russo P, Sullivan KE: Use of sirolimus in IPEX and IPEX-like children. J Clin Immunol 2008, 28(5):581-587.
21. Heltzer ML, Choi JK, Ochs HD, Sullivan KE, Torgerson TR, Ernst LM: A potential screening tool for IPEX syndrome. Pediatr Dev Pathol 2007, 10(2):98-105.
22. Torgerson TR, Linane A, Moes N, Anover S, Mateo V, Rieux-Laucat F, Hermine O, Vijay S, Gambineri E, Cerf-Bensussan N, Fischer A, Ochs HD, Goulet O, Ruemmele FM: Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 2007, 132:1705-1717.
23. Moes N, Rieux-Laucat F, Begue B, Verdier J, Neven B, Patey N, Torgerson TT, Picard C, Stolzenberg M-C, Ruemmele C, Rings EH, Casanova J-L, Piloquet H, Biver A, Breton A, Ochs HD, Hermine O, Fischer A, Goulet O, Cerf-Bensussan N, Ruemmele FM: Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology 2010, 139:770-778.
24. Hennezel E, Bin DK, Torgerson T, Piccirillo C: The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2012, 49:291-302.
25. Taddio A, Faleschini E, Valencic E, Granzotto M, Tommasini A, Lepore L, Andolina M, Barbi E, Ventura A: Medium-term survival without haematopoietic stem cell transplantation in a case of IPEX: insights into nutritionaland immunosuppressive therapy. Eur J Pediatr 2007, 166(11):1195-1197.
26. d'Hennezel E, Ben-Shoshan M, Ochs HD, Torgerson TR, Russell LJ, Lejtenyi C, Noya FJ, Jabado N, Mazer B, Piccirillo CA: FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N Engl J Med 2009, 361:1710-1713.
27. Dorsey MJ, Petrovic A, Morrow MR, Dishaw LJ, Sleasman JW: FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Immunol Res 2009, 44:179-184.
28. Rubio-Cabezas O, Minton JAL, Caswell R, Shield JP, Deiss D, Sumnik Z, Cayssials A, Herr M, Loew A, Lewis V, Ellard S, Hattersley AT: Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes. Diabetes Care 2009, 32:111-116.
29. Lucas KG, Ungar D, Comito M, Groh B: Epstein Barr virus induced lymphoma in a child with IPEX syndrome. Pediatr Blood Cancer 2008, 50:1056-1057.
30. Patey-Mariaud de Serre N, Canioni D, Ganousse S, Rieux-Laucat F, Goulet O, Ruemmele F, Brousse N: Digestive histopathological presentation of IPEX syndrome. Mod Pathol 2009, 22:95-102.
31. McMurchy AN, Gillies J, Allan SE, Passerini L, Gambineri E, Roncarolo MG, Bacchetta R, Levings MK: Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells. J Allergy Clin Immunol 2010, 126:1242-1251.